Profile: Collateral Therapeutics, Inc. focuses on the discovery and development of innovative non-surgical gene therapy products for the treatment of cardiovascular diseases. We enhance angiogenesis, a natural biological process, which stimulates the body's natural ability to grow new blood vessels. We offer natural & biological treatment for surgery, angioplasty and drug therapy, in order to increase levels of blood flow to oxygen-deprived tissues.